|
A High-Throughput Model for Human Melanoma
|
1R01CA121118-01A1
|
$229,100
|
HOLMEN, SHERI
|
NEVADA CANCER INSTITUTE
|
|
A new method for delivery of selinium for prevention of melanoma
|
5R03CA125854-02
|
$72,582
|
Cassidy, Pamela
|
UNIVERSITY OF UTAH
|
|
A Phase 0 Trial of Riluzole in Patients with Resectable Stage III or IV Melanoma
|
1R21CA126148-01
|
$204,380
|
GOYDOS, JAMES
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
|
5R01CA113796-02
|
$291,276
|
Frank, Markus
|
CHILDREN'S HOSPITAL BOSTON
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-32S1
|
$215,193
|
THOMPSON, CRAIG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-32
|
$7,282,327
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accuracy of In-vivo Confocal Imaging for Pigmented Lesion Diagnosis
|
5R44CA058054-05
|
$793,143
|
Eastman, Jay
|
LUCID, INC.
|
|
Adoptive T Cell Therapy of Melanoma Targeting NY-ESO-1
|
5R01CA104711-04
|
$334,292
|
YEE, CASSIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Altering Post Vaccination T Cell Contraction
|
3R01CA083672-07S1
|
$126,418
|
COLE, DAVID
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Altering Post Vaccination T Cell Contraction
|
5R01CA083672-07
|
$249,183
|
COLE, DAVID
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
An RNA Sensor for Detection of Circulating Tumor Cells
|
5R33CA118591-02
|
$284,503
|
CLAWSON, GARY
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Analysis of CD8 T cell responses to tumors
|
5R01CA071833-10
|
$282,084
|
DUTTON, RICHARD
|
TRUDEAU INSTITUTE, INC.
|
|
Analysis of Progression of the Transformed Phenotype
|
5R01CA035675-21
|
$317,951
|
FISHER, PAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Angiogenic Factors Associated with Uveal Melanoma
|
5R01CA103653-07
|
$376,608
|
POLANS, ARTHUR
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Anti-Cancer Activities of PTPase Inhibitors
|
5R01CA096636-05
|
$321,891
|
Yi, Taolin
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Anti-Tumor Autoimmunity by lymphopenia T cell Expansion
|
5R01CA109026-03
|
$313,314
|
BACCALA, ROBERTO
|
SCRIPPS RESEARCH INSTITUTE
|
|
Antigen Specific Immunotherapy with Transduced HSC
|
5R01CA100483-05
|
$344,936
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
Antigen specificity, suppressive mechanisms and regulation of CD4+ regulatory T c
|
5R01CA116408-02
|
$258,529
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Antiproliferative Potential of Polyamine Catabolism
|
5R01CA076428-09
|
$380,316
|
PORTER, CARL
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Apoptosis in Melanoma Progression and Chemoresistance
|
5R01CA107237-04
|
$285,035
|
SOENGAS, MARIA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Assessment and Optimization for Radiation Therapy
|
5R01CA050628-18
|
$373,347
|
NIEMIERKO, ANDRZEJ
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
ATF2 in DNA damage response.
|
5R01CA117927-02
|
$447,626
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
ATF2 in melanoma development and progression
|
5R01CA099961-05
|
$402,953
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Atlanta Regional Community Clinical Oncology Program
|
5U10CA045450-21
|
$623,000
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
Autoimmune vitiligo as a roadmap to melanoma therapy
|
5R01CA109536-03
|
$222,472
|
Le Poole, Isabelle
|
LOYOLA UNIVERSITY CHICAGO
|
|
Automatic Detection of Critical Dermoscopy Features for Melanoma Diagnosis
|
5R44CA101639-03
|
$494,442
|
STOECKER, WILLIAM
|
STOECKER & ASSOCIATES
|
|
B7-DC Cross-linking antibody immunotherapy
|
1R21CA130071-01
|
$285,291
|
MARKOVIC, SVETOMIR
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
Z01 BC 010856
|
$12,047,693
|
Custer, Mary
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Bayesian Models for Gene Expression with Microarray Data
|
5R01CA104620-03
|
$272,472
|
MALLICK, BANI
|
TEXAS A&M UNIVERSITY SYSTEM
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-06
|
$1,030,000
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Biochemistry of Melanins and Photoprotection of the Skin
|
Z01 BC 010784
|
$292,888
|
Hearing, Vincent
|
CCR (NCI)
|
|
Biology of Melanoma Matastasis
|
5R01CA047159-19
|
$308,264
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
Building on the success of the adoptive immunotherapy of cancer
|
Z01 BC 010763
|
$1,497,064
|
Restifo, Nicholas
|
CCR (NCI)
|
|
c-Myc Expression during Lymphomagenesis
|
5R01CA068328-11
|
$337,637
|
RUDDELL, M
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer and Leukemia Group B
|
5U10CA037447-24
|
$1,615,920
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-05
|
$341,771
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S2
|
$108,416
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S3
|
$113,053
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
5P30CA016042-33
|
$4,541,766
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
3P30CA016086-32S1
|
$89,905
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-32
|
$6,392,142
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support
|
3P30CA047904-20S1
|
$218,566
|
HERBERMAN, RONALD
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|